I partially agree with you. But BIEL's products like Allay, Recover RX were already discussed and applied for 510k in the past. So, FDA should have them listed long back but not sure why sudden listing after the May 9th meeting.
yes yes i understand you... buying (back) in at much much higher levels isn't fun aint it ...
So many people will get real headaches real soon here ....asking themselves.... 'why didnt i hold ... why didnt i hold '.... or... damn wished i had bought more (on the dipps).. wished i had bought more.... buying under the 0,005 range still possible but for how long... thats the million dollar question...
Dont hold youre breath thimking that possibility will remain for the coming weeks to come ...
The sp can recover real soon real quick to the former highs and establish a solid bottom from there real quick...
buying back in will become a nightmare for a lot of people ...thats just too bad...
Allay alone will be a game changer for the company... but offcourse thats not all by a long shot.
Total fda clearance can become a real possibility real quick